News blog

Regulatory advisers recommend new hepatitis C drug

Advisers to the US Food and Drug Administration (FDA) have unanimously recommended approval of one of the first therapies to directly target the hepatitis C virus (HCV).

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE